Protagen

Dortmund, Germany Founded: 1997 • Age: 29 yrs Acquired By Oncimmune
Autoantibody biomarkers are utilized for autoimmune disease diagnostics.
Annual revenue - Latest available
Total funding $19.8M 6 rounds
Employees 20 Tracked headcount
Investors 7 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Protagen

Protagen is a company based in Dortmund (Germany) founded in 1997 was acquired by Oncimmune in March 2019. Protagen has raised $19.84 million across 6 funding rounds from investors including Qiagen, NRW.Bank and Oncimmune. The company has 20 employees as of December 31, 2017. Protagen operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha, among others.

  • Headquarter Dortmund, Germany
  • Employees 20 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Protagen Ag
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $19.84 M (USD)

    in 6 rounds

  • Latest Funding Round
    Not available
  • Investors
    Qiagen

    & 6 more

  • Employee Count
    20

    as on Dec 31, 2017

  • Acquired by
    Oncimmune

    (Mar 19, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Protagen

Protagen has successfully raised a total of $19.84M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Protagen

Protagen has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, NRW.Bank and Oncimmune.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments in technology companies are managed by MIG Fonds.
Locked Locked Locked
VC Firm funding companies in Europe
Locked Locked Locked
Products and reagents for molecular diagnostic assays are supplied.
Locked Locked Locked
Premium access

Investor details for Protagen

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Protagen

Investments
Premium access

Investment portfolio details for Protagen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Protagen

Premium access

Detailed financials for Protagen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Protagen Comparisons

Protagen Primary company
Description
Autoantibody biomarkers are utilized for autoimmune disease ...
Location
Dortmund, Germany
Founded Year
1997
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
20
As of 2017
Premium access

Peer comparison for Protagen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Protagen

Protagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Kypha, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
Locked Locked Locked
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
Locked Locked Locked
T-cell-based diagnostics for infectious and immune diseases are developed.
Locked Locked Locked
Tools for diagnosing immune-mediated inflammatory diseases are developed.
Locked Locked Locked
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
Locked Locked Locked
Provider of immune monitoring reagents and services for research and clinical use
Premium access

Detailed competitors of Protagen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Protagen

Premium access

Complete news archive for Protagen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Protagen

Protagen was founded in 1997 and raised its 1st funding round 8 years after it was founded.

Protagen is headquartered in Dortmund, Germany. It is registered at Dortmund, North Rhine-westphalia, Germany.

Protagen is a funded company, having raised a total of $19.84M across 6 funding rounds to date.

As of Dec 31, 2017, the latest employee count at Protagen is 20.

Protagen is a provider of services, products and software solutions for protein research. Protagen provides products and GMP compliant services. The patented platform of protein expression libraries UNIclone allows Protagen the development of a new class of diagnostics based on autoantibody signatures in blood. Utilizing a personalized medicine approach, their multi-marker assay technology SeroTag; enables differential diagnosis and patient stratification for Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis and others. Protagen launched a research test in July 2014 for Systemic Sclerosis, secured by strong IP coverage and validated by proof-of concept studies in thousands of clinical samples.

Protagen's top competitors include Exagen, SmartHealth and HYCOR BioMedical.

Protagen has 7 investors. Key investors include Qiagen, NRW.Bank, Oncimmune, KfW, and MIG Fonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available